Opinion: Drug sensitivity and resistance testing could make ‘right to try’ a real thing
There's no catalog of available drugs that can help patients pursuing #RightToTry options. An updated technique once developed for cancer might match patients with experimental drugs.
The contentious “right to try” bill that President Trump signed into law to help terminally ill patients get access to treatments that might — I emphasize the “might” — cure them or prolong their lives is more wishful thinking than it is reality.
Right to try implies that a catalog of available drugs exists that can help patients if only they could get access to them. It’s easy to believe in a shelf of miracle cures to stop cancer — after all, media outlets are full of anecdotal stories of cancer patients who are now disease free.. But those cases are rare.
